tm logo
Trademark Search
ZYEPTI

View On IC.GC.CA

ZYEPTI
REGISTERED

on 15 Jun 2022

Last Applicant/ Owned by

H. LUNDBECK A/S

Ottiliavej 9DK-2500 VALBY

DK

Serial Number

2043947 filed on 25th Feb 2020

Registration Number

TMA1131727 registered on 15th Jun 2022

Registration expiry Date

25th Feb 2030

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

ZYEPTI

Trademark usage description

vaccines for humans; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting Read More

Classification Information

Class [005]
Vaccines for humans; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; pharmaceutical preparations and substances acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes, namely medical diagnostic reagents

Classification kind code

11

Mark Details

Serial Number

2043947

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 23rd Aug 2021		Search Recorded
Submitted for opposition 20
on 23rd Aug 2021		Examiner's First Report
Submitted for opposition 256
on 07th Jun 2021		Notification of Possible Opposition Sent
Submitted for opposition 48
on 15th Sep 2020		Agent Changed
Submitted for opposition 257
on 06th Aug 2020		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 06th Aug 2020		Formalized
Submitted for opposition 1
on 05th Aug 2020		Created
Submitted for opposition 30
on 25th Feb 2020		Filed
Submitted for opposition 228
on 25th Feb 2020		International Registration
Submitted for opposition 210
on 25th Feb 2020		IR Correction